CARA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CARA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cara Therapeutics's insider ownership is 4.08%.
Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cara Therapeutics's Institutional Ownership is 23.74%.
Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cara Therapeutics's Float Percentage Of Total Shares Outstanding is 71.72%.
The historical data trend for Cara Therapeutics's Insider Ownership can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cara Therapeutics Historical Data
The historical data trend for Cara Therapeutics can be seen below:
2023-06-30 | 2023-07-31 | 2023-08-31 | 2023-09-30 | 2023-10-31 | 2023-11-30 | 2023-12-31 | 2024-01-31 | 2024-02-29 | 2024-03-31 | |
Insider Ownership | 4.07 | 4.07 | 4.05 | 4.05 | 4.06 | 4.01 | 4.01 | 4.01 | 4.11 | 4.08 |
The percentage of shares that are owned by company insiders relative to the total shares outstanding.
Christopher Posner | director | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Helen M Boudreau | director | 200 TECHNOLOGY SQUARE, 4TH FLOOR, CAMBRIDGE MA 02139 |
Joana Goncalves | officer: Chief Medical Officer | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Scott Terrillion | officer: Sec'y; Chief Compliance & G.C. | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Menzaghi Frederique Ph.d. | officer: VP-Research & Development | C/O CARA THERAPEUTICS, INC., 1 PARROTT DRIVE, SHELTON CT 06484 |
Moltke Lisa Von | director | C/O SERESTHERAPEUTICS, INC., 200 SIDNEY STREET, CAMBRIDGE MA 02139 |
Martin Vogelbaum | director | 675 ALMANOR AVE, SUNNYVALE CA 94085 |
Ryan D Maynard | officer: Chief Financial Officer | RIGEL PHARMACEUTICALS, INC., 1180 VETERANS BLVD., SOUTH SAN FRANCISCO CA 94080 |
Csl Ltd | 10 percent owner | |
Jeffrey L. Ives | director | C/O CARA THERAPEUTICS, INC., 1 PARROTT DRIVE, SHELTON CT 06484 |
Bains Harrison M Jr | director | |
Thomas Charles Reilly | officer: Chief Financial Officer | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, STAMFORD CT 06902 |
Vifor Fresenius Medical Care Renal Pharma Ltd. | 10 percent owner | RECHENSTRASSE 37, CH-9014, ST. GALLEN V8 9014 |
Vifor (international) Ltd | 10 percent owner | RECHENSTRASSE 37, ST. GALLEN V8 9000 |
Vifor Pharma Ltd. | 10 percent owner | UNTERMATTWEG 8, BERNE V8 CH-3027 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-30-2022
By PurpleRose PurpleRose • 08-22-2022
By Value_Insider Value_Insider • 11-02-2022
By sperokesalga sperokesalga • 02-21-2023
By Marketwired • 09-25-2023
By PurpleRose PurpleRose • 08-24-2022
By Marketwired • 09-05-2023
By GuruFocusNews GuruFocusNews • 06-18-2022
By sperokesalga sperokesalga • 02-08-2023
By Value_Insider Value_Insider • 10-24-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.